Brown Capital Management LLC Sells 1,365,923 Shares of Enfusion, Inc. (NYSE:ENFN)

Brown Capital Management LLC lessened its holdings in Enfusion, Inc. (NYSE:ENFN) by 15.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,208,596 shares of the company’s stock after selling 1,365,923 shares during the quarter. Enfusion makes up approximately 1.5% of Brown Capital Management LLC’s holdings, making the stock its 25th biggest holding. Brown Capital Management LLC owned about 5.61% of Enfusion worth $68,410,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its stake in Enfusion by 57.5% in the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company’s stock valued at $4,466,000 after acquiring an additional 191,436 shares during the last quarter. Impax Asset Management Group plc boosted its position in shares of Enfusion by 25.4% in the 3rd quarter. Impax Asset Management Group plc now owns 676,948 shares of the company’s stock worth $6,424,000 after purchasing an additional 136,948 shares during the last quarter. Scalar Gauge Management LLC grew its stake in shares of Enfusion by 21.8% during the second quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company’s stock worth $5,227,000 after purchasing an additional 110,000 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Enfusion during the third quarter worth $892,000. Finally, Squarepoint Ops LLC bought a new stake in Enfusion in the second quarter valued at about $683,000. Institutional investors and hedge funds own 81.05% of the company’s stock.

Enfusion Trading Up 2.6 %

Enfusion stock opened at $9.89 on Thursday. The firm has a market capitalization of $1.27 billion, a P/E ratio of 247.31, a PEG ratio of 3.60 and a beta of 0.93. The business has a 50-day moving average of $9.10 and a 200-day moving average of $8.86. Enfusion, Inc. has a 1 year low of $7.52 and a 1 year high of $10.45.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.